Jamali Sarah, Dagher Michael, Bilani Nadeem, Mailhac Aurelie, Habbal Mohamad, Zeineldine Salah, Tamim Hani
Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Clinical Research Institute, Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
World J Surg. 2018 Sep;42(9):2763-2772. doi: 10.1007/s00268-018-4539-4.
Currently, only indirect evidence suggests that preoperative pneumonia is a significant risk factor for poor postsurgical outcomes. Although this relationship is clinically intuitive, this is the first study that aims to quantify the extent to which pneumonia impacts morbidity and mortality. The objective of this study was to determine the impact of preoperative pneumonia on 30-day mortality and morbidity among both elective and emergency surgical patients.
We conducted a retrospective cohort study using 2008-2012 data from the American College of Surgeons National Surgical Quality Improvement Program database. Patients with preoperative pneumonia were matched to controls without preoperative pneumonia. Patient demographics and postoperative outcomes were extracted from the database, including 30-day mortality, specific morbidities (wound, cardiac, respiratory, urinary, central nervous system, thromboembolism and sepsis), composite morbidity, number of blood transfusions and number of patients that returned to the OR. Mortality and composite morbidity were further stratified.
We obtained data for 137,174 patients, of whom 6933 (0.50%) had preoperative pneumonia. Overall, 6111 were successfully matched to 24,444 patients with no pneumonia. Postoperative mortality and composite morbidity were both higher in patients with pneumonia than in those without pneumonia, with an odds ratio of 1.37 (95% CI 1.26-1.48) and 1.68 (95% CI 1.58-1.79), respectively.
Preoperative pneumonia significantly increased the rate of postoperative morbidity and mortality across several surgical settings and patient groups. It is our recommendation that elective surgery be delayed until after the pneumonia resolves.
目前,仅有间接证据表明术前肺炎是术后不良结局的一个重要风险因素。尽管这种关系在临床上是直观的,但这是第一项旨在量化肺炎对发病率和死亡率影响程度的研究。本研究的目的是确定术前肺炎对择期和急诊手术患者30天死亡率和发病率的影响。
我们使用美国外科医师学会国家外科质量改进计划数据库2008 - 2012年的数据进行了一项回顾性队列研究。将术前有肺炎的患者与无术前肺炎的对照组进行匹配。从数据库中提取患者人口统计学和术后结局信息,包括30天死亡率、特定并发症(伤口、心脏、呼吸、泌尿、中枢神经系统、血栓栓塞和败血症)、综合并发症、输血次数以及返回手术室的患者数量。对死亡率和综合并发症进行进一步分层。
我们获取了137174例患者的数据,其中6933例(0.50%)有术前肺炎。总体而言,6111例成功匹配到24444例无肺炎患者。肺炎患者的术后死亡率和综合并发症均高于无肺炎患者,优势比分别为1.37(95%可信区间1.26 - 1.48)和1.68(95%可信区间1.58 - 1.79)。
术前肺炎在多种手术情况和患者群体中显著增加了术后发病率和死亡率。我们建议择期手术推迟至肺炎痊愈后进行。